Opioid Substitution to Improve the Effectiveness of Chronic Noncancer Pain Control: A Chart Review
暂无分享,去创建一个
M. Wallace | S. Magnuson | N. Quang‐Cantagrel | Nathalie Do Quang-Cantagrel | Scott K. Magnuson | Scott K. Magnuson | Nathalie Do Quang‐Cantagrel
[1] S. Wessely,et al. Medication misuse, abuse and dependence in chronic pain patients. , 1997, Journal of psychosomatic research.
[2] E. Kharasch,et al. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[3] C. Stein. Opioid Treatment of Chronic Nonmalignant Pain1 , 1997, Anesthesia and analgesia.
[4] D. Jasinski. Tolerance and dependence to opiates , 1997, Acta anaesthesiologica Scandinavica.
[5] L. Christrup. Morphine metabolites , 1997, Acta anaesthesiologica Scandinavica.
[6] S. Savage. Long-term opioid therapy: assessment of consequences and risks. , 1996, Journal of pain and symptom management.
[7] R. Portenoy,et al. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. , 1996, Journal of pain and symptom management.
[8] H. Merskey,et al. Randomised trial of oral morphine for chronic non-cancer pain , 1996, The Lancet.
[9] N. Cherny. Opioid analgesics: comparative features and prescribing guidelines. , 1996, Drugs.
[10] H. Markley. Chronic headache: Appropriate use of opiate analgesics , 1994, Neurology.
[11] D. Ziegler,et al. Opiate and Opioid Use in Patients With Refractory Headache , 1994, Cephalalgia : an international journal of headache.
[12] A. Dickenson. Neurophysiology of opioid poorly responsive pain. , 1994, Cancer surveys.
[13] D. Denson,et al. Clinical efficacy of methadone in patients refractory to other μ‐opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross‐tolerance among opioid agonist analgesics , 1993, Cancer.
[14] T. Yaksh,et al. Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy. , 1993, Anesthesia and analgesia.
[15] P. Masand,et al. Chronic Nonmalignant Pain Treated with Long-Term Oral Narcotic Analgesics , 1992 .
[16] A. Jadad,et al. Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia , 1992, The Lancet.
[17] G. Pasternak,et al. Individual variability in the response to different opioids: report of five cases , 1992, Pain.
[18] M Tryba,et al. Long-term oral opioid therapy in patients with chronic nonmalignant pain. , 1992, Journal of pain and symptom management.
[19] G. Pasternak,et al. Genetic influences in opioid analgesic sensitivity in mice , 1991, Brain Research.
[20] R. Portenoy,et al. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions , 1990, Pain.
[21] T. Yaksh,et al. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. , 1990, Anesthesiology.
[22] M. Cousins,et al. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer , 1986, Pain.
[23] Russell K. Portenoy,et al. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases , 1986, Pain.
[24] H. Jick,et al. Addiction rare in patients treated with narcotics. , 1980, The New England journal of medicine.